EMCDDA	European Monitoring Centre for Drugs and Drug Addiction
EUDA	European Union Drugs Agency
ISS	Istituto Superiore di Sanità
SNAP	System Network on New Psychoactive Substances
AIFA	Italian Medicines Agency
LSD	Lysergic Acid Diethylamide
LSA	Lysergic Acid Amide
CNS	Central Nervous System
DMT	N,N-Dimethyltryptamine
MAO	Monoamine Oxidase
MAOIs	Monoamine Oxidase Inhibitors
5-OH-DMT	5-Hydroxy-N,N-Dimethyltryptamine
5-MeO-DMT	5-Methoxy-N,N-Dimethyltryptamine
Δ9-THC	Δ-9-Tetrahydrocannabinol
SCs	Synthetic Cannabinoids
CB1	Cannabinoid Receptor 1
CB2	Cannabinoid Receptor 2
HU-210	(6aR,10aR)-9-(Hydroxymethyl)-6,6-Dimethyl-3-(2-Methyloctan-2-yl)-6a,7,10,10a-Tetrahydrobenzo[c]chromen-1-ol
CP-47947	5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-Hydroxycyclohexyl]-Phenol
AM-4030	(6S,6aR,9R,10aR)-9-(Hydroxymethyl)-6-[(E)-3-Hydroxyprop-1-Enyl]-6-Methyl-3-(2-Methyloctan-2-yl)-6a,7,8,9,10,10a-Hexahydrobenzo[c]chromen-1-ol
AM-1220	(Naphthalen-1-yl)[1-[(1-Methylpiperidin-2-yl)Methyl]-1H-Indol-3-yl]Methanone
THJ-018	Naphthalen-1-yl[1-(Pent-1-yl)-1H-Indazol-3-yl]Methanone
THJ-2201	1-(5-Fluoropent-1-yl)-1H-Indazol-3-ylMethanone
5F-APINACA	N-(1-Adamantyl)-5-Fluoropentyl-1H-Indazole-3-Carboxamide
MDMB-FUBINACA	Methyl 2-[1-(4-Fluorobenzyl)-1H-Indazole-3-Carboxamido]-3,3-Dimethylbutanoate
ADB-FUBINACA	N-(1-Amino-3,3-Dimethyl-1-Oxobutan-2-yl)-1-(4-Fluorobenzyl)-1H-Indazole-3-Carboxamide
AB-CHMINACA	N-(1-Amino-3-Methyl-1-Oxobutan-2-yl)-1-(Cyclohexylmethyl)-1H-Indazole-3-Carboxamide
MAB-CHMINACA	N-(1-Amino-3,3-Dimethyl-1-Oxobutan-2-yl)-1-(Cyclohexylmethyl)-1H-Indazole-3-Carboxamide
AM-356	N-(2-Hydroxy-1R-Methylethyl)-5Z,8Z,11Z,14Z-Eicosatetraenamide
EPH	Ephedrone
MDPV	3,4-Methylenedioxypyrovalerone
βk-MDMA	3,4-Methylenedioxy-N-Methylcathinone
MDPBP	Methylenedioxy-α-Pyrrolidinobutyrophenone
4-MMC	4-Methylmethcathinone, 4-Methylephedrone
βk-MBDB	1,3-Benzodioxol-5-yl)-2-(Methylamino)Butan-1-one
PMMA	Paramethoxymethamphetamine
2C-B	4-Bromo-2,5-Dimethoxyphenethylamine
2C-I	4-Iodo-2,5-Dimethoxyphenethylamine
2C-T-7	2,5-Dimethoxy-4-(n)-Propylthiophenethylamine
DOB	2,5-Dimethoxy-4-Bromoamphetamine
DOI	2,5-Dimethoxy-4-Iodoamphetamine
25I-NBMOe	2-(4-Iodo-2,5-Dimethoxyphenyl)-N-[(2-Methoxyphenyl)Methyl]Ethanamine
4-APB	4-(2-Aminopropyl) Benzofuran
5-APB	5-(2-Aminopropyl) Benzofuran
6-APB	6-(2-Aminopropyl) Benzofuran
DiTP	Di-Isopropyltryptamine
4-OH-DiPT	4-Hydroxy-N,N-Diisopropyltryptamine
BZP	1-Benzylpiperazine
mCPP	1-(m-Chlorophenyl) Piperazine
TFMPP	1-(m-Trifluoromethylphenyl) Piperazine
2-DPMP	2-Diphenylmethylpiperidine
D2PM	Diphenyl-2-Pyrrolidinyl-Methanol
MOTUs	Molecular Operational Taxonomic Units
BLAST	Basic Local Alignment Search Tool
BOLD-IDS	Barcode of Life Database Identification System
SEM	Scanning Electron Microscopy
TEM	Transmission Electron Microscopy
EDS	X-ray Energy Dispersive System
LOD	Limit of Detection
LOQ	Limit of Quantification
SPE	Solid-Phase Extraction
RP-HPLC-DAD	Reverse-Phase High-Performance Liquid Chromatography Coupled with Diode Array Detector
LC-MS	Liquid Chromatography Coupled with Mass Spectrometry
LC-MS/MS	Liquid Chromatography Tandem Mass Spectrometry
GC-MS	Gas Chromatography Coupled with Mass Spectrometry
GC-FID	Gas Chromatography Coupled with Flame Ionization Detector
ADHD	Attention Deficit-Hyperactivity Disorder
CUD	Caffeine Use Disorder
3-MMC	3-Methylmethcathinone
CE	Cognitive Enhancers
COMT	Catechol-O-Methyltransferase
PTSD	Post-Traumatic Stress Disorder